Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Poseida Therapeutics (PSTX)

  • Event
  • Aug. 03, 2022, 20:29 UTC
  • 19
  • 1 comments

(10% Negative) Poseida Therapeutics, Inc. (PSTX) Announces Clinical Trial Timeline Adjustment

Comment Full text

Xencor Inc (XNCR)

  • Event
  • Aug. 03, 2022, 20:12 UTC
  • 18
  • 1 comments

(30% Negative) XENCOR, INC. (XNCR) Reports Q3 2022 Financial Results

Comment Full text

Vanda Pharmaceuticals Inc (VNDA)

  • Event
  • Aug. 03, 2022, 20:12 UTC
  • 19
  • 1 comments

(19% Negative) VANDA PHARMACEUTICALS INC. (VNDA) Reports Q3 2022 Financial Results

Comment Full text

Jazz Pharmaceuticals plc (JAZZ)

  • Event
  • Aug. 03, 2022, 20:07 UTC
  • 17
  • 1 comments

(10% Negative) Jazz Pharmaceuticals plc (JAZZ) Reports Q3 2022 Financial Results

Comment Full text

Mirati Therapeutics Inc (was acquisied by Bristol Myers Squibb (NYSE: BMY) on 23/01/2024) (MRTX)

  • Event
  • Aug. 03, 2022, 20:04 UTC
  • 18
  • 1 comments

(30% Negative) MIRATI THERAPEUTICS, INC. (MRTX) Reports Q3 2022 Financial Results

Comment Full text

Fate Therapeutics Inc (FATE)

  • Event
  • Aug. 03, 2022, 20:03 UTC
  • 18
  • 1 comments

(10% Negative) FATE THERAPEUTICS, INC. (FATE) Reports Q3 2022 Financial Results

Comment Full text

Personalis Inc (PSNL)

  • Event
  • Aug. 03, 2022, 20:01 UTC
  • 18
  • 1 comments

(30% Negative) Personalis, Inc. (PSNL) Reports Q3 2022 Financial Results

Comment Full text

Spectrum Pharmaceuticals Inc (was acquised by Assertio Holdings, Inc (NASDAQ:ASRT) on 31/07/2023) (SPPI)

  • Event
  • Aug. 03, 2022, 14:17 UTC
  • 19
  • 1 comments

(99% Neutral) SPECTRUM PHARMACEUTICALS INC (SPPI) Provides Business Update

Comment Full text

Geron Corporation Inc (GERN)

  • Event
  • Aug. 03, 2022, 13:32 UTC
  • 101
  • 0 comments

Geron - Wedbush PacGrow Healthcare Conference 2022

Comment Full text

Landos Biopharma Inc (was acquired by AbbVie Inc. (NYSE: ABBV) on 25/03/2024) (LABP)

  • Event
  • Aug. 03, 2022, 12:30 UTC
  • 19
  • 1 comments

(90% Positive) Landos Biopharma, Inc. (LABP) Announces Enrollment Update for milestone Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Comment Full text
  • Previous
  • 236
  • 237
  • 238
  • 239
  • 240
  • Next

Search

News categories

  • Technical Exchange News(11463)
  • Event(3242)
  • SEC News(211680)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(136811)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin